Celltrion gets green light for Phase 1 clinical trial of 'Tremfya' biosimilar in South Korea Asia Today 2d
Celltrion's Truxima becomes 1st interchangeable rituximab biosimilar in US Korea Biomedical Review 01:33 Wed, 01 Jul Truxima Genentech Teva All sources
Celltrion draws bullish broker outlooks after second straight sales beat Korea Biomedical Review 02:27 Wed, 08 Jul Biotechnology
Samsung, SK lead Chungcheong investment push The Dong-a Ilbo 00:39 Fri, 03 Jul Samsung Top Tech Brands IT
Veradermics oral, extended-release minoxidil shows efficacy in female hair loss Scrip Pharma Intelligence 14h
Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy Pharmaceutical Technology 17h Biotech Biotechnology
Mandrake Bio raises Rs 16 crore to build AI-powered gene-editing platform for agriculture, medicine The Economic Times 19h AI CRISPR/Gene Editing Biotechnology
